Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Acquires Eppendorf s Reagent Business; Firms to Align Techs

NEW YORK, Jan. 5 (GenomeWeb News) - Qiagen has acquired Eppendorf's reagent business for an undisclosed amount, and the two companies have penned an alliance to co-develop and -market certain life-science products for biological sample-management and analysis, Qiagen said today.

Eppendorf's reagent business includes the Eppendorf "5-Prime" nucleic acid sample-preparation and PCR reagent product lines and related intellectual property, according to Qiagen.


The assets also comprise a "promising" pipeline of technologies for nucleic acid handling, separation, purification, and amplification.


Financial terms of the acquisition were not disclosed. However, Qiagen said it expects the reagent business to add $6 million in net sales in 2006 and $11 million in 2007. Qiagen generated $380 million in revenues in 2004, the most current annual period for which figures are available. As part of the deal, Qiagen said it also expects to incur $3 million in one-time in the fourth quarter 2005.

The alliance between the companies is intended to marry certain of the firms' technologies. For example, Eppendorf is known for its liquid-handling instruments, including pipettes, centrifuges, PCR cyclers, and work stations. Qiagen, meantime, is known for its preanalytical sample-prep tools, among other instruments and consumables. Their alliance aims to improve biological sample-management and analysis.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.